Drug Shortage Report for ROBITUSSIN AC
Report ID | 199216 |
Drug Identification Number | 01934740 |
Brand name | ROBITUSSIN AC |
Common or Proper name | Guaifenesin, Codeine Phosphate and Pheniramine Maleate Syrup |
Company Name | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CODEINE PHOSPHATE GUAIFENESIN PHENIRAMINE MALEATE |
Strength(s) | 10MG 100MG 7.5MG |
Dosage form(s) | SYRUP |
Route of administration | ORAL ORAL |
Packaging size | 1 L |
ATC code | R05FA |
ATC description | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-06-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-08-17 |
Company comments | This will be a permanent discontinuation. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 55 STANDISH COURT MISSISSAUGA, ONTARIO CANADA L5R 4B2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2023-08-17 | English | Compare |
v2 | 2023-07-19 | French | Compare |
v1 | 2023-07-19 | English | Compare |
Showing 1 to 3 of 3